Can Paxlovid treat long Covid? A new report suggests it might help some patients, but which patients might benefit remains unclear. The report, published Monday in the journal Communications Medicine, describes the cases of 13 long Covid patients who took extended courses of the antiviral drug. Results were decidedly mixed: Nine patients reported some improvement, … Read more
For people suffering through a bout of COVID-19, the antiviral Paxlovid has been a godsend. The medication emerged as the go-to antiviral treatment during the pandemic emergency after the Food and Drug Administration granted it emergency use authorization in December 2021. Now, there’s a new antiviral that’s superior to Paxlovid — but Americans can’t get … Read more
Nursing homes and their residents were on the front lines in the battle against COVID-19. But despite how vulnerable nursing home residents are to severe illness and death from the disease, most of them never received lifesaving drugs — including Paxlovid, approved by the Food and Drug Administration in May this year, after more than … Read more
CNN — Covid-19 patients with a history of cardiovascular disease are at an increased risk of developing severe illness and could benefit most from the Covid-19 treatment Paxlovid – but there’s a catch. Paxlovid can have dangerous interactions with some of the most common medications for cardiovascular disease, including certain statins and heart failure therapies, … Read more
A neurologist at a prestigious U.S. research institute has developed an experimental COVID treatment he calls “true revenge” that weaponizes the virus against itself. The treatment, dubbed NMT5, was created by Scripps Research Institute’s Neurodegeneration New Medicines Center founding director Dr. Stuart Lipton and a team of scientists. It’s a derivative of memantine, an Alzheimer’s … Read more
Taking Pfizer’s blockbuster COVID-19 pills, Paxlovid, at the same time as a rival’s treatment for the virus might be safe and more effective than either drug alone, federal scientists have found. The combination might also offer a solution to so-called “rebound” cases, when patients see a return of symptoms after finishing off a course of … Read more